| 000 | 01365 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512010651.0 | ||
| 264 | 0 | _c19900130 | |
| 008 | 199001s 0 0 eng d | ||
| 022 | _a0340-7004 | ||
| 024 | 7 |
_a10.1007/BF01669422 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEberlein, T J | |
| 245 | 0 | 0 |
_aImmunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans. _h[electronic resource] |
| 260 |
_bCancer immunology, immunotherapy : CII _c1989 |
||
| 300 |
_a145-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xpharmacology |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _xpharmacokinetics |
| 650 | 0 | 4 |
_aKiller Cells, Lymphokine-Activated _ximmunology |
| 650 | 0 | 4 |
_aLymphocytes _ximmunology |
| 650 | 0 | 4 |
_aNeoplasms _xtherapy |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacokinetics |
| 700 | 1 | _aRodrick, M L | |
| 700 | 1 | _aMassaro, A F | |
| 700 | 1 | _aJung, S E | |
| 700 | 1 | _aMannick, J A | |
| 700 | 1 | _aSchoof, D D | |
| 773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 30 _gno. 3 _gp. 145-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01669422 _zAvailable from publisher's website |
| 999 |
_c2604080 _d2604080 |
||